You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Julia Kaye1,2,3, Naufa Amirani1,3, Úna Chan1,3
1Center for Systems and Therapeutics, Gladstone Institutes, San Francisco, CA 94158, USA.
Machine learning decodes cellular signatures in amyotrophic lateral sclerosis (ALS), identifying nuclear changes and early disease events. This approach helps stratify ALS patients and understand disease heterogeneity for targeted therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: